Ubs Group Ag Novartis Ag Call Options Transaction History

Ubs Group Ag

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 13, 2024	BUY	$92.57 - $107.37 $1.39 Million - $1.61 Million	15,000 New	15,000 $1.6 Million
Q1 2022 May 16, 2022	SELL	$80.11 - $90.62 $6.45 Million - $7.29 Million	-80,500 Reduced 99.75%	200 $18,000
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $5.62 Million - $6.21 Million	70,500 Added 691.18%	80,700 $7.06 Million
Q1 2020 May 01, 2020	SELL	$70.67 - $99.01 $1.84 Million - $2.57 Million	-26,000 Reduced 71.82%	10,200 $841,000
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $522,986 - $582,342	7,100 Added 24.4%	36,200 $3.11 Million
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $1.4 Million - $1.62 Million	-20,900 Reduced 41.8%	29,100 $2.51 Million
Q4 2017 Feb 14, 2018	BUY	$72.33 - $77.64 $3.62 Million - $3.88 Million	50,000	50,000 $4.2 Million

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.